Open company graph database — free web & API
Login

Ark Medical Solutions Inc.

ArkMS株式会社アークメディカルソリューションズAliasArkMS株式会社(アークメディカルソリューションズ)Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
263
Related companies
10
§01

Basic information

BASIC
Head office
13th Floor, Hareza Tower, 1-18-1 Higashiikebukuro, Toshima-ku, Tokyo 170-0013, Japan
Chief executive
Saku Mizuo
Capital
300,000,000  (3 100 million)
Employees (non-consolidated)
263 people
Employees (consolidated)
263 people
Start date
2024-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

14
CRO businessClinical trials of pharmaceuticals, medical devices, regenerative medicine, etc.Clinical researchPost‑marketing surveillanceDatabase researchDatabase research supportClinical development (clinical trials, physician‑initiated trials)Clinical research (interventional studies, observational studies, surveys)Post‑marketing surveillance (PMS)Safety information management (GVP)Database research and studiesMedical information and customer centerAdverse event spontaneous reporting database (FAERS/JADER)Global services
§04

Related companies

10 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Alfresa Holdings Corporation
Group
XClinical社
Alliance
M-Wiz Inc.
Alliance
PSP Corporation
Ascendro Corporation
Alfresa Holdings Corporation
Shareholder
Intage Healthcare Inc.
Canon Medical Systems Corporation
京都コンステラ・テクノロジーズ
Agrimedia Inc.
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

47 EVENTS

1992 IBRD JAPAN Inc. EstablishmentSources

Established IBRD JAPAN Inc.Sources

In 2000, all shares of IBRD JAPAN Co., Ltd. were transferred to the Social Research Institute Co., Ltd. (renamed Intage Co., Ltd. in 2001) and became a 100% subsidiary.Sources

All shares of IBRD JAPAN Inc. were transferred to the Social Survey Research Institute Co., Ltd. (renamed Intage Co., Ltd. in 2001) and became a 100% subsidiarySources

In 2003, the Medical Solutions Division of IBRD JAPAN Co., Ltd. and Intage Co., Ltd. was merged, and the company name was changed to Asclep Co., Ltd.Sources

Integrated the medical solutions division of IBRD JAPAN Inc. and Intage Co., Ltd. and simultaneously changed the company name to Asklep Co., Ltd.Sources

In 2004, EDC solution services for post‑marketing surveillance were launched.Sources

Started providing EDC solution services for post‑marketing surveillanceSources

In 2008, a strategic license grant and development agreement with XClinical (Germany) was signed, and the EDC system "MARVIN" was introduced.Sources

In 2008, a strategic partnership agreement with overseas CROs was signed, and global operations were fully launched.Sources

Signed a strategic licensing and development agreement with XClinical (Germany) and implemented the EDC system "MARVIN"Sources

Entered a strategic partnership agreement with an overseas CRO and fully launched global operationsSources

In 2010, a local subsidiary was established in China (ASKLEP CHINA Inc. / 阿思克瑞普医药諮詢(上海)有限公司).Sources

Established a local subsidiary in China (ASKLEP CHINA Inc.)Sources

2012 PPCJ Inc. absorbed and mergedSources

2012 Established a local subsidiary in Taiwan (Taiwan ASKLEP Biotech Consulting Co., Ltd. / ASKLEP TAIWAN Inc.)Sources

2012 Established a local subsidiary in Korea (아스크랩코리아 / ASKLEP KOREA Inc.)Sources

Absorbed and merged with PPCJ Co., Ltd.Sources

Established a local subsidiary in Taiwan (ASKLEP TAIWAN Inc.)Sources

Established a local subsidiary in South Korea (ASKLEP KOREA Inc.)Sources

2013 Established RPS Asklep Inc. (JVC) in KoreaSources

Established RPS Asklep Inc. (JVC) in South KoreaSources

2014 Divided the clinical development business and related operations to ATE Health Care Co., Ltd. (new corporation). At the same time, transferred shares of the corporation, overseas local subsidiaries (China, Taiwan, Korea), and RPS Asklep Inc. to Itochu CorporationSources

Divided the clinical development business and related activities to ATE Health Care Co., Ltd. (new corporation). At the same time, transferred shares of the company, overseas local subsidiaries (China, Taiwan, South Korea), and RPS Asklep Inc. to Itochu CorporationSources

2015 Capital and business alliance with Kyoto Constellation TechnologiesSources

2015 Released new version "ADDIN EX" of the post-manufacturing survey EDC "ADDIN"Sources

Entered a capital and business alliance with Kyoto Constellation TechnologiesSources

Released a new version "ADDIN EX" of the post-manufacturing sales investigation EDC "ADDIN"Sources

2016 Capital and business alliance with Assembly Log Co., Ltd.Sources

2016 Kyoto Constellation Technologies Co., Ltd. became a subsidiarySources

Entered a capital and business alliance with Assembly Org Co., Ltd.Sources

Made Kyoto Constellation Technologies a subsidiarySources

2018 Launched patient association support service using the eCOQOLO appSources

2018 Participated in Kyoto University’s one‑stop bio resource project "KBBM Co., Ltd."Sources

2018 Joined a consortium that supports the entire process from clinical development to sales for pharmaceutical and medical device companiesSources

Launched a "Patient Association Support Service" using the app "eCOQOLO"Sources

Participated in the one-stop bio-resource business "KBBM Co., Ltd." at Kyoto UniversitySources

Joined a consortium that supports pharmaceutical and medical device companies from clinical development to sales in a one-stop mannerSources

2019 Merged Asklep Co., Ltd. and Antelio Co., Ltd., both part of the Intage Group’s healthcare division, and established Intage Healthcare Co., Ltd.Sources

Intage Group’s healthcare division, Asklep Co., Ltd. and Antelio Co., Ltd. merged to establish Intage Healthcare Co., Ltd.Sources

2024 Divested CRO business from Intage Healthcare to ArkMS Co., Ltd. (new corporation). At the same time, became a full subsidiary of Alphressa Holdings Co., Ltd.Sources

Divided the CRO business from Intage Healthcare to ArkMS Co., Ltd. (new corporation) and fully acquired by Alfresa Holdings Co., Ltd.Sources

Established ArkMS Co., Ltd.Sources

2026 Signed a business transfer agreement with Remedia Co., Ltd.Sources

2026 Signed a business alliance agreement with M-Wiz Co., Ltd.Sources

Signed a business transfer agreement with Remedia Co., Ltd.Sources

Signed a business alliance agreement with M-Wiz Co., Ltd.Sources

§07

News

10 ARTICLES

Microsoft 365 Outage Impacting InquiriesSources

Due to a Microsoft 365 system outage, emails addressed to ArkMS Inc. may not be received. Submissions via the website contact form may also fail to be received. For urgent matters, please call us. We will provide updates on the recovery status as soon as possible.

Notice of Resumption of Contact Form AcceptanceSources

The contact form that was temporarily suspended has been restored and is now available for use as usual. We have instructed those who contacted us during the suspension period to contact us again. We apologize for any inconvenience caused.

Notice of Temporary Suspension of the Contact Form (Resolved)Sources

Currently, due to a system outage, we are unable to receive messages from the contact form, so we have temporarily suspended its operation. We will notify you again once the issue is resolved.

Contact Form RestoredSources

The contact form, which had been temporarily unavailable due to a system failure, was restored on August 24, 2026. It is now available for use as usual.

Notice of Osaka Office RelocationSources

ArkMS Co., Ltd.'s Osaka office will begin operations at its new address (5th Floor, Honmachi Highest Building, 4-7-5 Awajimachi, Chuo-ku, Osaka, Osaka Prefecture) on July 16, 2026. The company says that all employees will strive to do even better following the relocation.

President Interview Featured in Pharmaceutical Daily Report 'CRO/SMO Special'Sources

An interview article featuring ArkMS Co., Ltd.'s President and CEO, Naoto Mizuo, was published in the Pharmaceutical Daily Report 'CRO/SMO Special' issued on June 29, 2026. The article introduces the expansion of specialized areas of CRO services and ArkMS's CRO functions in the Alfressa Group's 'TSCS'.

Notice of Information Disclosure under the Worker Dispatch LawSources

In accordance with Article 23, Paragraph 5 of the Worker Dispatch Act, we are publishing information about our worker dispatch business. The margin rate for fiscal year Reiwa 6 is listed.

Notice of New Year's HolidaySources

The company will be closed from Saturday, December 27, 2025, to Sunday, January 4, 2026, for the New Year's holiday. We appreciate your understanding.

Head Office Relocation NoticeSources

ArkMS Corporation has relocated its headquarters to enhance the quality of communication and provide better services. Operations at the new office will commence on November 4, 2025, and the location is 13th floor, Hareza Tower, 1-18-1 Higashi-Ikebukuro, Toshima-ku, Tokyo.

Announcement of Osaka Office RelocationSources

ArkMS Corporation's Osaka office began operations at its new address on February 14, 2025. The new address is 6-38 Oosumachi, Kita-ku, Osaka City, Osaka Prefecture, Grangreen Osaka North Building, JAM BASE 3rd floor, JAM STUDIO 305.

§08

Public records

GOV
National Tax Agency basic information9013301053062
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
ArkMS株式会社
Trade name (kana)
アークメディカルソリューションズ
Name in English
Corporation type
301
Address
〒170-0013 東京都豊島区東池袋1丁目18番1号
Postal code
1700013
Prefecture code
13
City code
116
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2024-09-11
Update date
2025-11-13
Change date
2025-11-04
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
0
Trade name image ID
Address image ID
Sequence number
2599831
METI gBizINFO9013301053062
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
9013301053062
Trade name
ArkMS株式会社
Trade name (kana)
アークメディカルソリューションズ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都豊島区東池袋1丁目18番1号
Postal code
1700013
Prefecture
東京都
Prefecture code
13
City or district
豊島区
City code
116
Street address
東池袋1丁目18番1号
Organisation type
301
Processing type
12
Correction type
0
Status
Representative
代表取締役 水尾 斉
Capital
Employees
200
Employees (male)
78
Employees (female)
119
Business summary
Website URL
https://www.arkms.co.jp/
Year founded
Business category
L:学術研究、専門・技術サービス業
Date established
2024-09-02
Unified government qualification - grade
||C|
Unified government qualification - business items
303|304|306|315
Update date
2025-11-13
Key information
9013301053062
§09

Sources & updates

SOURCES
↑